Skip to content

Monthly Archives: February 2010

Exploratory Analysis of the Association between New-Type Drug Use and Sexual Transmission of HIV in China.

Conclusion: The study results suggest that ATS users significantly contribute to the sexual transmission of HIV. Scientific Significance: It is helpful to evaluate and predict the potential risk factors related with epidemic of HIV in China and provide theoretical evidence for HIV/AIDS health officers and policy makers to better construct target interventions and implement control measures. PMID: 20337511 [PubMed - in process] (Source: The American Journal of Drug and Alcohol Abuse)

Differential Racial/Ethnic Patterns in Substance Use Initiation among Young, Low-Income Women.

Conclusions: To be optimally effective, prevention efforts may need to be tailored to fit the race/ethnicity of the audience. Further studies are suggested to investigate specific risk factors related to substance use initiation by race/ethnicity. PMID: 20337510 [PubMed - in process] (Source: The American Journal of Drug and Alcohol Abuse)

Anxiety and mood disorders and cannabis use.

Conclusion: These data provide epidemiological evidence for a link between both light and heavy cannabis use and AMD. Scientific Significance: Recognizing the comorbidity of heavy cannabis use and AMD should facilitate improved treatment efforts

Factor Structure of the Chinese Version of the University of Rhode Island Change Assessment in Taiwanese Adolescents Who Abuse MDMA or…

Conclusions: The results indicated that the URICA may have different factor structures when used in the population different from the original adult population with alcohol drinking. PMID: 20337508 [PubMed - in process] (Source: The American Journal of Drug and Alcohol Abuse)

Determinants of cue-elicited craving and physiologic reactivity in methamphetamine-dependent subjects in the laboratory.

Conclusions: Cue-induced craving for methamphetamine may be reliably measured in methamphetamine-dependent individuals in the laboratory. Further studies employing the cue reactivity paradigm in methamphetamine dependence are warranted

Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence.

Conclusion: These results indicate that zonisamide administration may not impair verbal fluency in ADS, and are consistent with other studies that found zonisamide administration may reduce alcohol intake. PMID: 20337506 [PubMed - in process] (Source: The American Journal of Drug and Alcohol Abuse)

Hyperammoneic encephalopathy, valproic Acid, and benzodiazepine withdrawal: a case series.

Conclusions: Hyperammoneic encephalopathy can occur as a distinct entity separate from hepatotoxicity with the use of valproic acid and may be an unrecognized complication among patients receiving this drug during benzodiazepine detoxification. Scientific Significance: A previously unreported complication among the addiction patient population is reported. This underscores the need for a better evidence base regarding the prevention of seizures during acute benzodiazepine detoxification, particularly in terms of indications, safety, and efficacy.

Risk Practices Associated with Bacterial Infections among Injection Drug Users in Denver, Colorado.

Conclusion: Intervention strategies to reduce bacterial infections should focus on high-risk injection practices. Scientific Significance: Learning about rates of bacterial infections and high-risk practices associated with these infections can benefit researchers developing risk reduction interventions for IDUs. PMID: 20337504 [PubMed - in process] (Source: The American Journal of Drug and Alcohol Abuse)

Adolescent drug dealing and race/ethnicity: a population-based study of the differential impact of substance use on involvement in drug trade.

Conclusions and Scientific Significance: For White youths, substance use seems to be more relevant to drug dealing. Consequently, preventing and treating substance abuse may reduce involvement in the illegal distribution of drugs among White youths. More research is needed to identify risk and protective factors for drug dealing among Black adolescents.

Cannabis Science Moves Its FDA Clinical Trial Process Forward

Cannabis Science Inc. (NASD OTCBB: CBIS), a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials…